About Index Trending news
Analyze
Top 50 Pricing
Ignyta

Ignyta

Ignyta

Kindling the revolution in personalized medicine. Helping to extinguish cancer

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO debt
$42,000,000
Post-IPO equity
$42,000,000
Employees

Team size

10+
Locations
HQ
Xconomy

In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial

$42,000,000 Post-IPO debt
businesswire

Ignyta Secures $42 Million Term Loan Facility | Business Wire